Article Listing - NEW YORK STOCK COMMENT

EUROPE'S PHARMA INDUSTRY IN 1990

9 March 1992

Total pharmaceutical production in 1990 by the national member companies of the European Federation of Pharmaceutical Industries' Association in 16...

VOLUME GROWTH FOR US DRUGMAKERS

9 March 1992

The US pharmaceutical industry in general shows particularly impressive unit growth characteristics, according to Steven Gerber of New York securities...

AUSTRALIAN DRUG PRICES IN LATE 91

9 March 1992

Pharmaceutical prices in Australia increased by 1.23% on average during the period from September to December 1991, according to the...

GERMAN PHARMACY MARGINS ROW

9 March 1992

The German pharmacists' federation, the BVDA, has rejected criticisms of fixed pharmacy and wholesale margins made by the industrial health...

QUIDEL PLEASED WITH 3RD QUARTER

9 March 1992

Quidel Corporation, which merged a year ago with Monoclonal Antibodies, made sales in the third quarter ending December 31, 1991,...

BARR LABS 2nd QTR NET INCOME DOWN

9 March 1992

Barr Laboratories in the USA made sales for the second quarter ended December 31, 1991 of $30.6 million, up 18.6%...

STUDY CONTRACT FOR EC DRUG AGENCY

9 March 1992

The Commission of the European Communities has awarded a contract for a one-year study of the requirements for the...

EURO MARKET FOR DRUG INTERMEDIATES

9 March 1992

The western European market for high-value pharmaceutical intermediates will grow from $565 million in 1991 to $678 million by 1996,...

STOCK MARKET COMMENTARY: TOKYO

9 March 1992

TOKYO: edged up in thin volume last week, to close up 2.5%. The low volume attests to the fact that...

REPLIGEN R&D PARTNERSHIP

9 March 1992

Repligen Corp of the USA has formed an R&D partnership to test and develop recombinant platelet factor-4, which has potential...

Showing 94711-94720 of 95368 articles